Mar 11, 2009 - The Gamida Cell-Teva Joint Venture announced today that orphan designation was granted by the European Commission for the investigational medicinal product StemEx for the treatment of acute lymphoblastic leukemia and acute myeloid leukemia.
The details can be read here.
No comments:
Post a Comment